chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Large itchy rash covering torso, chest; Arm and legs hives; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 15Apr2021 at 12:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 23Apr2021 at 19:00, the patient experienced large itchy rash covering torso, chest and some hives on arms and legs. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with antihistamines (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events large itchy rash covering torso, chest and some hives on arms and legs was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Nausea; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the arm left on 02Mar2021 at 13:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ethinylestradiol, norethisterone acetate (JUNEL) and dietary supplements; from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021 at 13:15, the patient experienced nausea and dizziness. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea and dizziness were recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
bumps that were flesh/skin tone, not red, on her hands/she developed bumps on her palms and fingers; bumps on her palms and fingers; This is a spontaneous report from a contactable nurse (patient). A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730) on 08Jan2021 at single dose for COVID-19 immunisation (to prevent COVID). Medical history and concomitant medication were none. patient received vaccine on 08Jan2021 and 9 days later (17Jan2021) developed "bumps that were flesh/skin tone, not red, on her hands", she asked if this has been associated with the product. Patient sked if there have been any reports of coxsackievirus (Hand-foot-mouth disease) with the vaccine. It was also reported she says got the first vaccine 08Jan and 9 days later she developed bumps on her palms and fingers, it happened this Sunday. She doesn't know if it might be work related she works with cleaning supplies and wearing gloves in the hospital but she did get the vaccine so she is wondering if that is a side effect that anyone else has called about. She clarifies the bumps are not red they are skin color, they are only red if she scratches them. When they started out she only had about 3 now she has about 20. Patient was not recovered from the events. It was a non-serious report.
Symptoms appeared 2 weeks after receiving the Varicella vaccine. Noticed many bumps on my son's upper arms. Over the next 24 house the bumps spread to his whole arms, shoulders, whole legs and a few on his back. His face, chest and stomach were not affected. Most of the bumps started out as not colored except his elbows and ankles which were large red welts. Over the past week these have been itchy and have now turned to red sore like scabs which are worse on his legs and shoulders. The welts remain. He is not sick otherwise (except runny nose) and has no fever. The clinic where it was administered as well as a pediatrician said they had not seen this reaction before. He was told to take Benadryl and was prescribed a cortisone cream. I have photos if required.
Mom started complaining she was itching  all over her body appx 2 days after 2nd injection.  We saw red bumps and gave her topical benadryl, but irritation still persisted.  We called her primary Dr and she recommended we give her oral benadryl.  Yesterday we were out to lunch and the way home mom fainted in the car so we called an ambulance.  They kept her over night for observation.
I had a high fever 103 I had severe body aches and couldn't stop shaking so severely it affected my breathing so I went to ER and was fluids through IV because of severe dehydration.
Patient called 7/26/13 1:30p stating area was red, hot, swollen and hard (baseball size). Last night at 9:30-10pm temperature 101.0 degrees F took TYLENOL then temp 7/26/13 a.m. 99.0 degrees F. Temp has increased to 100.0 degrees F at 2:54pm pt stopped in Rx dept. Area baseball size hard red hot advised cold compresses 20 min on 20 off and to stop by her primary to see if they want to treat (if a cellulitis suspected).
Information has been received from a licensed practical nurse concerning a 26 year old female patient who on 24-APR-2007 was vaccinated with her third dose of Gardasil. On 24-APR-2007 the patient experienced shooting pains in her arm. In addition, she had no range of motion with her arm. She did not have this experience with the first two doses. As of 03-MAY-2007, the patient's shooting pains in her arm and no range of motion with her arm persisted. Additional information has been requested. 07/06/07 This is in follow-up to report(s) previously submitted on 6/14/2007. Initial and follow-up information has been received from a licensed practical nurse concerning a 26 year old female who on 24-APR-2007 was vaccinated with her third dose of GARDASIL. On 24-APR-2007 the patient experienced shooting pains in her arm. In addition, she had no range of motion with her arm. She did not have this experience with the first two doses. As of 03-MAY-2007, the patient's shooting pains in her arm and no range of motion with her arm persisted. Patient did not come in for her evaluation. The licensed practical nurse presumed the problem had resolved. Additional information not expected.
More than 42 days for administration of the second dose; Daughter received Moderna shot at 16 years of age; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Daughter received Moderna shot at 16 years of age) and PRODUCT DOSE OMISSION ISSUE (More than 42 days for administration of the second dose) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Daughter received Moderna shot at 16 years of age). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 42 days for administration of the second dose). On 02-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Daughter received Moderna shot at 16 years of age) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 42 days for administration of the second dose) had resolved.            No treatment information was provided.
On the 1/15 I noticed swollen lymph nodes. One on my right shoulder and base of the left side of my neck.  The one on my right side went away in about two weeks and the one on my left side is still here till this day.  I made appt. with my PCP and he ran some blood test with no abnormal findings.  I also have thalassemia trait.  The day after I had a fever of 99 and back muscle pain due to those two I left work for the day.
From my diary about the events of yesterday and today:   I will try to relate what happened to me yesterday.   I received my second Covid vaccination a few days ago and perhaps the following is related, but I?m not sure.  I think I felt fine yesterday morning, and decided to scrub my tub. I was mostly finished when I felt dizzy and went to lie down around 1pm.  A friend texted me asking if I was free for a chat, but I wanted to rest a little and did so, texting her when I awoke.  I did feel out of sorts when I awoke, and was aware that I had had some dreams, but texted her anyway.  We agreed to have a call at 2pm.  While on the call, I felt I was struggling with the conversation.  I was trying to tell her of my experiences with a recent part-time job (which I quit) and couldn?t remember names of people I worked with or certain events that I wished to convey.  I still can?t remember names of people with whom I worked, and it was just one week ago that I left.  I suddenly felt really out of it and nauseous, and struggled to tell my friend I needed to get off the phone.  I could not remember her name, to tell her this (and I've known her for 40 years)!   The next few hours are a total fog.  I know I was having dreams of a sort, but I was not asleep.  There are maybe 2 hours that I can?t account for. It is most troubling to me that I can?t account for this time, but I know something was happening with my brain and while I was having these dreams or hallucinations, I was not asleep. I remember having to think really hard about what my son-in-law?s name was ? note that I live with this person.  I did not seek medical care, but feel like this information could be related to the Covid vaccine, and may be important to you.  It was my night to cook, and I had a really hard time keeping up.  I did manage to pull most of a meal together, but right before I was done, I needed to call my daughter to finish it.  I was unable to eat anything myself, and only wanted a drink.  I felt really nauseous and unsteady, although my thinking was a bit more clear by this time.  I?m not sure when the numbness in my toes and fingers on one side of my body (right side) started, but as of this afternoon, both are still numb and weak.  It is 1:00pm and I am still having trouble remembering some things, and that few hours of the afternoon from yesterday are completely lost to me.  I have like a shadow hanging above one eye. I am seriously thinking I have had some sort of a neurological event.  As of 3:00 today, my right hand and right foot are still numb, although my thinking seems to be clear.
Rheumatoid arthritis flare up; MARKETTING PROGRAM NAME NOT AVAILABLE  This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (not available). The reporter is the patient. Other Case identifier(s): 21K-163-4191463-00 (Abbvie).  A 45 year-old patient received bnt162b2 (BNT162B2), intramuscular, administration date 28Dec2020 (Batch/Lot number: unknown) at the age of 45 years as dose 1, single and intramuscular, administration date 17Jan2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Batch/Lot number: unknown) for rheumatoid arthritis. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RHEUMATOID ARTHRITIS (medically significant), outcome "not recovered", described as "Rheumatoid arthritis flare up". It was unknown if patient was enrolled in a Covid-19 Vaccine Trial. The action taken for adalimumab was unknown.  The reporter considered "rheumatoid arthritis flare up" related to bnt162b2. The reporter's causality for the event(s) of Rheumatoid Arthritis Flare Up with Humira(Adalimumab) was no reasonable possibility.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the currently available information the possibility of causal association between the event Rheumatoid arthritis flare up and the suspect drug BNT162B2  is assessed as not related. The case will be reassessed once new information (event date) is available.
after both pfizer vaccines plus a booster shot I was tested positive in feb 2022 while travelling No symptoms but had to quarantine locally for 6 days until my wife and I could fly home.  we then isolated for 5 more days upon return.
Initial report was received 25 August 2011 from a consumer, who is the patient's parent. An 18-year-old female patient had received an intramuscular injection of ADACEL, an intramuscular injection of MENACTRA, and a subcutaneous injection of VARIVAX (manufacturer Merck) on 21 July 2011 (lot numbers and sites of administration not reported) and 14 days later on 04 August 2011, the patient developed nausea, vomiting, diarrhea, shivering and flu-like symptoms resulting in two emergency room visits due to dehydration. The patient received unspecified treatments and was released. The patient had no illness at the time of vaccination, no pre-existing medical conditions and she had not been taking any concomitant medications. At the time of the report, the patient had lost eight pounds and had not recovered. Documents held by sender: None.
Covid-19: diarrhea, sore throat, cough, headache, head and chest congestion, vertigo, fatigue, brain fog, sinus pressure. Started morning of 9/22 like a mild sinus infection. Quickly increased or flu-like symptoms by afternoon or 9/23. Took 2 rapid tests that were immediately positive.
Mild chronic hives, multiple sites of 1cm flat bumps that itch; Mild chronic hives, multiple sites of 1cm flat bumps that itch; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) in the left arm on 26Feb2021(at the age of 73-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) for unspecified indication on unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1283) in the left arm on 05Feb2021(at the age of 73-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced mild chronic hives, multiple sites of 1cm flat bumps that itched. The sites quickly resolved following application of topical triple antibiotic cream. They continued to appear without intervention. The patient reported that half tablet of zyrtec antihistamine suppressed symptoms for about four days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported events which included treatment with topical triple antibiotic cream and zyrtec antihistamine. The clinical outcome of the event mild chronic hives, multiple sites of 1cm flat bumps that itched was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
I received my third dose of the Pfizer vaccine on November 1, 2021.  I experienced a fever, body aches, fatigue for two days starting November 2nd.  On November 7th, I noticed that I was experiencing pain in my right leg and muscle fatigue or weakness.  I visited my doctors office and the NP diagnosed me with Trochanteric Bursitis.  NP stated that bursitis may have been an inflammatory response to the vaccine, but she had not had any prior reports from other patients so could not say for certain.  Symptoms have since dissipated.  On December 5th, I noticed a rash on my abdomen on the right side.  I was experiencing strange skin sensations as well.  I saw the NP on December 6th and was diagnosed with Shingles.  I was prescribed Valtrex HCI 1 GM tab 3x daily for 7 days.
screaming "fit" of 10-15 mins w/t101 the next day; knot the size of a nickel @ the inject site; pt recovered as of 3JUN93;
Profuse bloody nose from both nostrils at the same time.  There was a lot of ?pressure? behind the bleeding, making it almost pulsate out of my nose. Tried laying down, but there was too much blood pooling in my throat. I couldn?t  keep Kleenex fast enough before it would soak up the blood. This lasted about 20 minutes before I had good control. My blood pressure is normally 123/82, I took it during this episode/time, it was 140/104 and 153/108. The following morning my blood pressure was back to normal.
Sick; Ringing in my ears; My left arm, I can hardly use it; Dizzy; I fall over; I can't really remember what I am doing at the time; I can hardly get up; It did some kind of damage, it hurts; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 16Mar2021 (Lot number: EP7534) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Sick"; TINNITUS (non-serious), outcome "unknown", described as "Ringing in my ears"; MUSCULOSKELETAL DISORDER (non-serious), outcome "unknown", described as "My left arm, I can hardly use it"; DIZZINESS (non-serious), outcome "unknown", described as "Dizzy"; FALL (non-serious), outcome "unknown", described as "I fall over"; MEMORY IMPAIRMENT (non-serious), outcome "unknown", described as "I can't really remember what I am doing at the time"; DYSSTASIA (non-serious), outcome "unknown", described as "I can hardly get up"; PAIN (non-serious), outcome "unknown", described as "It did some kind of damage, it hurts".  Additional information: The patient just can't get back and it has been about ten days.  No follow-up attempts are possible. No further information is expected.
PATEINT REPORTED EVENT TO PHARMACY 9/8/22. THE PATIENT STATES THAT THE ARM WAS SORE FROM THE VACCINE IMMEDIATELY AFTER THE VACCINE AS EXPECTED, BUT THE SORENESS NEVER SUBSIDED AND STATES THAT THE PAIN GOT WORSE THIS MOST RECENT WEEK. WHEN SDESCRIBING THE PAIN, HE SAYS IT IS DULL, AND IS EXACERBATED BY PHYSICAL ACTIVITY/EXERCISE. THE PAIN IS LOCALIZED TO THE MUSCLE BUT HE CANNOT PINPOINT. THERE IS NO REDNESS OR HEAT AT THE INJECTION SITE.
Headache, Myalgia, Diarrhea, FATIGUE/CHILLS/BODYACHES/DIARRHEA/HEADACHE/SCRATCHY THROAT/PHLEGN Narrative:
Erythema surrounding injection site and then on 9/13/14 erythema worsened and induration noted.  Put ice on it immediately.
(R) arm, erythema, warmth, edematous, upper arm. Unable to lift arm.
A 102 temperature and malaise for 48 hours post shot. Then, as fever broke, right arm became very red, hard, and hot. Approximate area was 8" x 8" the first day and grew to include about 80% of my upper arm over the course of the next two days. With the help of OTC and Rx antihistamines, it slowly resolved itself by day 6 after the shot.
This case was reported by a consumer (subject) and described the occurrence of difficulty thinking in a 77-year-old male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included bleeding ulcer, gastroesophageal reflux disease, gout, high blood pressure, hydrocephalus and shunt placed. Concurrent medications included Lisinopril, PRILOSEC, Triamterene + hydrochlorothiazide and Allopurinol. On 28 September 2013 at 11:00 the subject received 1st dose of FLULAVAL (unknown details, left deltoid). On 1 October 2013, 3 days after vaccination with FLULAVAL, the subject experienced difficulty thinking, prolonged recovery, walking difficulty and fatigue. The subject reported that the "progress with my hydrocephalus with shunt placement slowed down since my flu shot". The subject reported that he was "not walking as well, unable to pick up feet, taking smaller steps". This case was assessed as medically serious by GSK. At the time of reporting the events were unresolved.
Pt recvd 1st vax on Engerix-B on 17JUN91 & 1 hr p/inject, pt exp hypotension, blurred vision, dizziness, nausea & SOB; sx resolved p/8hrs w/o tx;
A 77-year-old female patient reports feeling nauseated and vertigo just at the time of registering for post-vaccination waiting. Note: Patient reports suffering from vertigo.
11/7/07 at 4pm vaccines administered. 11/8/07 patient calls reporting arm pain at IPV injection site. No redness/fever/swelling. Advised NSAID, cold compress. Calls later that day. in "extreme" pain. Advised -> ER. Refused. (spoke to- NP) 11/9/07 called patient at home in am. Trying to get in with her PCP. will call her if she can't to let us see her. -> over 11/9/07 at 5 pm I called patient later when I hadn't heard back from her. own PCP couldn't see her - she went to ER. X-rays/labs negative. Sent home on pain meds. No infection. Just woke up. I informed patient I would file VAERS report on pain seemed in excess of 'Normal' sxn..
Cluster of 2 patients (patient identified in case 2006-02903; patient not identified in case 2006-02904).  This case has the same reporter as case 2006-02904.
Patient stated that on Friday 9/20 she started getting chills and a headache. On Saturday 9/21 she developed a red rash looking area below the injection site roughly palm sized, it was red, hot, and sore to the touch. By Sunday 9/22, the rash was still present and was still warm, but she was able to touch it.
Redness and moderate itching has begun at injection site. Area begins about 1/2 " above site and extends down approx. 5" and is 2" wide. area is swollen and hard to touch and tender.